ProPhase Labs, Inc. company info

CIK 868278
IRS Number 232577138
State of incorporation DE
Business address 621 N. SHADY RETREAT ROAD
Mail address 621 N. SHADY RETREAT ROAD

Short summary

ProPhase Labs, Inc. is a Pennsylvania company, with head office located at 621 N. Shady Retreat Road Doylestown, Pennsylvania 18901. In 2019 the company owned a total of 12.38 million USD worth of assets, including 10.24 million USD worth of current assets. 2016 was the year when the company amassed the most assets.

ProPhase Labs, Inc. Income Statement

Name [in Millions USD]200820092010201120122013201420152016201720182019Trends
Revenue, Net 19.8214.5017.4522.4125.0322.072.5221.019.87
Cost of Goods and Services Sold 8.255.676.178.158.367.898.433.217.928.357.26
Gross Profit 11.578.8311.2814.2516.6714.1812.181.001.954.782.62
Research and development 1.310.791.091.300.821.320.340.360.430.400.33
Operating Expenses 15.5012.4214.0215.3516.2622.0115.764.795.946.425.85
Operating Income (Loss) -3.94-3.59-2.74-1.100.42-7.83-3.58-2.66-3.99-1.63-3.24
Interest expense
Other Nonoperating Income (Expense)
Income Tax Expense (Benefit) -0.08-0.04000-1.420.10
Net income -3.84-3.50-2.71-1.090.41-7.83-3.60-2.8740.59-1.74-3.15

ProPhase Labs, Inc. Balance Sheet

Name [in Millions USD]200820092010201120122013201420152016201720182019Trends
Cash and cash equivalents 11.9611.168.744.614.067.353.761.1537.283.671.052.54
Accounts Receivable, Net, Current 1.160.941.132.341.251.801.841.360.741.93
Inventories 1.593.
Property, Plant and Equipment, Gross 5.926.236.636.947.668.318.218.438.51
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 3.583.733.984.204.514.925.275.666.066.38
Total assets 17.7515.1815.0719.7612.0411.5450.1022.1215.8012.38
Current assets 11.809.189.0013.679.188.4842.2219.5513.4310.24
Accounts payable 0.130.531.031.400.651.370.920.450.440.84
Taxes Payable, Current 0.750.740.00
Total current liabilities 5.796.404.475.953.585.183.471.600.961.40
Long-term Debt, Excluding Current Maturities 0.10
Long-term Debt 1.60
Total liabilities 1.151.48
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -3.98-7.32-7.22-9.33-16.17-19.2822.658.992.28-2.25
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.05-0.000.00

ProPhase Labs, Inc. Cash Flow

Name [in Millions USD]200820092010201120122013201420152016201720182019Trends
Net income -3.84-3.50-2.71-1.090.41-7.83-3.60-2.8740.59-1.74-3.15
Depreciation 0.360.360.
Depreciation and amortization 0.520.360.360.
Deferred Income Tax Expense (Benefit) 0.05-0.900.760.22-2.55-1.48-1.0016.090.14
Accounts receivable -2.491.22-1.602.19-0.090.52-1.841.77-3.831.02-0.94
Inventories -0.960.280.89-0.640.470.771.04-1.60-1.210.37-0.44
Accounts payable -0.11-0.220.400.41-0.29-0.340.321.17-1.59
Net Cash Provided by (Used in) Operating Activities 0.45-3.55-2.11-5.731.14-3.22-3.50-0.47-2.84-2.12-0.84
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Productive Assets 0.140.23
Payments to Acquire Intangible Assets 03.6000
Net Cash Provided by (Used in) Investing Activities 0.27-1.15-0.13-0.31-0.44-0.31-0.71-0.6521.7711.865.54
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.13-0.31-0.44-0.31
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.630.74
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.630.74
Proceeds from Issuance of Common Stock 001.070.444.911.56
Payments for Repurchase of Common Stock 16.28
Net Cash Provided by (Used in) Financing Activities 0.130.13-0.451.070.374.812.94-0.10-16.20-11.36-5.82
Cash and Cash Equivalents, Period Increase (Decrease) 0.84-4.57-2.69-4.971.071.29-1.26-1.222.73